Press Releases :: VolitionRx Ltd (VNRX)

Jan 6, 2021 • 8:25 AM EST VolitionRx Limited Awarded an Additional $4 Million in Non-Dilutive Funding

Dec 3, 2020 • 8:30 AM EST VolitionRx Limited Appoints Dr. Tom Butera DVM to Board of Directors

Dec 1, 2020 • 8:45 AM EST Volition Launches Nu.Q™ Vet Cancer Screening Test in the U.S.

Nov 19, 2020 • 7:00 AM EST VolitionRx Limited to Present COVID-19 Data at MEDICA 2020

Nov 12, 2020 • 4:10 PM EST VolitionRx Limited Announces Third Quarter 2020 Financial Results and Business Update

Nov 10, 2020 • 8:00 AM EST Volition Veterinary Presents Expert Report Ahead of First Product Launch

Nov 9, 2020 • 8:00 AM EST VolitionRx Limited Schedules Third Quarter 2020 Earnings Conference Call and Business Update

Oct 21, 2020 • 8:00 AM EDT VolitionRx Limited Releases Video of Virtual Capital Markets Day 2020

Oct 20, 2020 • 7:00 AM EDT VolitionRx Limited Announces Details for Virtual Capital Markets Day 2020

Oct 16, 2020 • 8:00 AM EDT Volition Veterinary Diagnostics Development LLC Announces Product Data Regarding its Nu.Q™ Vet Cancer Screening Test in Lymphoma and Hemangiosarcoma to be Presented at the 2020 VCS Virtual Annual Conference

1
2
3
4
5
6
7
8
9
10
...25
Next »